Abstract P2-09-26: Real world progression free survival in elderly vs. younger HR+/HER2- advanced breast cancer patients treated with first-line endocrine therapy plus CDK4/6i: a sub-analysis of the multicenter, PALMARES-2 studyFrancesca Ligorio, Claudio Vernieri, Giuseppe Curigliano et al.|Clinical Cancer Research|2025Cited by 0